# Kristen NooShin Ganjoo, M.D. – FDA Inspection, Jun 17, 2024

Source: https://www.keypedia.com/records/fda_inspections/kristen-nooshin-ganjoo-md/f3dfdba8-e0ee-4cfd-870b-91fbd8664d75
Source feed: FDA_Inspections

> FDA inspection 1241519 of Kristen NooShin Ganjoo, M.D., June 17, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241519
- Company Name: Kristen NooShin Ganjoo, M.D.
- Inspection Date: 2024-06-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1135959 - 2021-02-08

## Related Officers

- [Investigator](https://www.keypedia.com/people/cynthia-j-tsui/e02b5fd2-e90b-47a7-bbc2-e658f160c4ae)
- [Linh Tu](https://www.keypedia.com/people/linh-tu/142c94dc-9538-4c52-9a5f-be27fc7c4f4b)

Company: https://www.keypedia.com/companies/kristen-nooshin-ganjoo-md/b3d084ef-4aec-473e-8f1c-a95e8de6f078

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d